将 B 细胞与浆细胞靶向从肿瘤学转化至自身免疫:模式、定量桥接与开发路线图 Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. PubMed 2026/06/05 发表Clin Pharmacol TherQ1 · IF 4.9(JCR 2025) 靶点:CD19靶点:CD20靶点:CD38技术:双特异性抗体淋巴瘤骨髓瘤
接受 daratumumab 治疗的结外 NK/T 细胞淋巴瘤患者的免疫特征分析 Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab. PubMed 2024/01/18 发表Ann HematolQ3 · IF 2.3(JCR 2025) 靶点:CD38技术:NK 细胞非霍奇金淋巴瘤地区:中国地区:美国
idecabtagene vicleucel 治疗复发/难治性多发性骨髓瘤:近期进展综述 Idecabtagene vicleucel for relapsed/refractory multiple myeloma: a review of recent advances. PubMed 2022/03/01 发表Drugs Today (Barc) 靶点:CD38靶点:BCMA技术:CAR-T多发性骨髓瘤地区:中国地区:美国